Antidepressant-Warfarin interaction and associated gastrointestinal bleeding risk in a case-control study

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Schelleman, Hedi ^a   Brensinger, Colleen M ^a   Bilker, Warren B ^a   Hennessy, Sean ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; VENLAFAXINE; WARFARIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAID; OBSERVATIONAL STUDY; RISK ASSESSMENT; ADOLESCENT; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; MIDDLE AGED; RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DRUG INTERACTIONS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; WARFARIN; YOUNG ADULT;

EID: 79959604823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021447     Document Type: Article

References (24)

1. (2007) FDA approves updated warfarin (Coumadin) prescribing information. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108967. htm Accessed on September 23, 2010.
2. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S, (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115: 2689-2696.
3. Hansen ML, Sorensen R, Clausen MT, Fog-Petersen ML, Raunso J, et al. (2010) Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 170: 1433-1441.
4. Kurdyak PA, Juurlink DN, Kopp A, Herrmann N, Mamdani MM, (2005) Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol 25: 561-564.
5. (2010) Drug Facts & Comparisons answers, http://online.factsandcomparisons.com, Accessed January 14, 2010.
6. (2010) MICROMEDEX 2.0, http://www.thomsonhc.com/micromedex2/librarian, Accessed: January 14, 2010.
7. Hansten PD, Horn JR, (2010) Drug Interactions Analysis and Management 2010 St. Louis Wolters Kluwer Health.
8. Schmider J, Greenblatt DJ, von Moltke LL, Karsov D, Shader RI, (1997) Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation. Br J Clin Pharmacol 44: 495-498.
9. de Abajo FJ, Rodriguez LA, Montero D, (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319: 1106-1109.
10. Dunn NR, Pearce GL, Shakir SA, (2000) Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding. BMJ 320: 1405-1406.
11. van Walraven C, Mamdani MM, Wells PS, Williams JI, (2001) Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323: 655-658.
12. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, et al. (2003) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163: 59-64.
13. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, et al. (2004) Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164: 2367-2370.
14. Opatrny L, Delaney JA, Suissa S, (2008) Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 66: 76-81.
15. Chen Y, Guo JJ, Patel NC, (2009) Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter? Pharmacoepidemiol Drug Saf Mar 18: 196-202.
16. Schalekamp T, Klungel OH, Souverein PC, de Boer A, (2008) Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168: 180-185.
17. Wallerstedt SM, Gleerup H, Sundstrom A, Stigendal L, Ny L, (2009) Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 18: 412-416.
18. Tournier M, Moride Y, Lesk M, Ducruet T, Rochon S, (2008) The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec. Can J Clin Pharmacol 15: e22-35.
19. Hennessy S, Carson JL, Ray WA, Strom BL, (2005) Pharmacoepidemiology: Medicaid databases. In: Strom BL, editors. Pharmacoepidemiology. 4th ed Chichester John Wiley and Sons pp. 281-294.
20. Hennessy S, Leonard CE, Palumbo CM, Newcomb C, Bilker WB, (2007) Quality of Medicaid and Medicare Data Obtained Through Centers for Medicare and Medicaid Services (CMS). Med Care 45: 1216-1220.
21. Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, et al. (2010) Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med 123: 151-157.
22. Flanders WD, Louv WC, (1986) The exposure odds ratio in nested case-control studies with competing risks. Am J Epidemiol 124: 684-692.
23. Mickey RM, Greenland S, (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129: 125-137.
24. Tatsumi M, Groshan K, Blakely RD, Richelson E, (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340: 249-258.